|
1 |
H.619 |
An Act establishing a prescription drug rebate program for seniors |
Nicholas A. Boldyga |
|
2 |
S.1106 |
An Act specifying an electronic system to ensure that sales of certain products containing pseudoephedrine (PSE) do not exceed limits established under federal law |
Pavel Payano |
|
3 |
H.1176 |
An Act relative to promoting comprehensive transparency in the pharmaceutical industry |
Edward F. Coppinger |
|
4 |
H.1182 |
An Act relative to the treatment of epilepsy and seizure disorders |
Michael S. Day |
|
5 |
H.1197 |
An Act to provide rapid whole genome sequencing |
Danielle W. Gregoire |
|
6 |
H.1201 |
An Act to promote transparency in prescription drug prices |
Kate Hogan |
|
7 |
H.1205 |
An Act relative to prescription drug price transparency |
Bradley H. Jones, Jr. |
|
8 |
H.1206 |
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth |
Bradley H. Jones, Jr. |
|
9 |
H.1208 |
An Act establishing a state-wide drug repository program |
Bradley H. Jones, Jr. |
|
10 |
H.1215 |
An Act relative to pharmacy benefit managers |
John J. Lawn, Jr. |
|
11 |
H.1243 |
An Act to ensure access to the full range of treatment options for people with obesity |
Jon Santiago |
|
12 |
H.1246 |
An Act relative to drug prices paid by carriers |
William M. Straus |
|
13 |
H.1247 |
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth |
Alyson M. Sullivan-Almeida |
|
14 |
S.732 |
An Act relative to promoting comprehensive transparency in the pharmaceutical industry |
John J. Cronin |
|
15 |
S.749 |
An Act relative to pharmaceutical access, costs and transparency |
Cindy F. Friedman |
|
16 |
S.754 |
An Act to ensure access to the full range of treatment options for people with obesity |
Adam Gomez |
|
17 |
S.767 |
An Act to define modest meals and refreshments in prescriber education settings |
Jason M. Lewis |
|
18 |
S.778 |
An Act to bring down the cost of prescription drugs |
Paul W. Mark |
|
19 |
S.783 |
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices |
Mark C. Montigny |
|
20 |
S.784 |
An Act relative to coverage for chronic illness |
Mark C. Montigny |
|
21 |
S.797 |
An Act to bring down the cost of prescription drugs |
Jacob R. Oliveira |